KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $342,915 | -22.0% | 2,028 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $439,772 | -85.8% | 2,028 | -87.2% | 0.00% | -88.0% |
| Q4 2022 | $3,107,058 | -12.6% | 15,812 | 0.0% | 0.02% | -19.4% |
| Q3 2022 | $3,556,593 | +105.7% | 15,812 | +15.7% | 0.03% | +121.4% |
| Q2 2022 | $1,728,886 | +10.9% | 13,666 | +11.1% | 0.01% | +40.0% |
| Q1 2022 | $1,559,390 | +48.8% | 12,299 | +53.7% | 0.01% | +11.1% |
| Q4 2021 | $1,048,262 | +7.1% | 8,002 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $978,885 | +35.4% | 8,002 | +33.0% | 0.01% | +28.6% |
| Q1 2021 | $723,183 | +3.0% | 6,015 | -13.0% | 0.01% | 0.0% |
| Q4 2020 | $702,393 | +31.4% | 6,914 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $534,590 | -30.6% | 6,914 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $770,634 | +130.9% | 6,914 | +49.2% | 0.01% | +80.0% |
| Q1 2020 | $333,720 | +94.8% | 4,635 | +103.8% | 0.01% | +150.0% |
| Q4 2019 | $171,323 | – | 2,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |